2017
DOI: 10.1016/j.jemermed.2016.12.022
|View full text |Cite
|
Sign up to set email alerts
|

Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model with Septic Shock Phenotype

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In recent years, The Pediatric Sepsis Biomarker Risk Model (PERSEVERE, PERSEVERE II, and PERSEVERE-XP) biomarker panels based on patient genome studies have been developed to identify the risk of death in septic shock in children. PERSEVERE biomarkers are generally associated with inflammation and cellular damage, which makes it highly likely to identify the risk of deterioration in a particular child with septic shock [50], [51], [52].…”
Section: Sirsmentioning
confidence: 99%
“…In recent years, The Pediatric Sepsis Biomarker Risk Model (PERSEVERE, PERSEVERE II, and PERSEVERE-XP) biomarker panels based on patient genome studies have been developed to identify the risk of death in septic shock in children. PERSEVERE biomarkers are generally associated with inflammation and cellular damage, which makes it highly likely to identify the risk of deterioration in a particular child with septic shock [50], [51], [52].…”
Section: Sirsmentioning
confidence: 99%